Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study

Ikeda, S, Ueda, Y, Hara, M, et al. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case‐control study. Cancer Sci. 2020; 00: 1– 8. https://doi.org/10.1111/cas.14682

An ancillary study of participants in a randomized, placebo-controlled trial suggests that ingestion of bovine lactoferrin promotes expression of interferon alpha in the human colon

AbstractStudies using animal models have demonstrated that ingestion of bovine lactoferrin (bLF) is able to induce cytokine expression in the intestine and inhibit carcinogenesis in the colon and other organs of experimental animals. Consequently, a clinical trial was conducted in the National Cancer Center Hospital, Tokyo, Japan to determine whether ingestion of bLF affected the growth of colorectal polyps in humans. The Tokyo-trial found that ingestion of 3.0 g bLF suppressed the growth of colorectal polyps and increased the level of serum human lactoferrin in participants 63 years old or younger. The present study is a complementary study to the Tokyo-trial to determine if a change in the expression of one or more cytokines could be detected in the colon of the Tokyo-trial participants after ingesting bLF. We found that daily ingestion of 3.0 g bLF promoted the expression of interferon alpha in the colon of the Tokyo-trial participants

Infección, Cáncer y Prevención: Informe del 19º Simposio Internacional de la Fundación para el Fomento de la Investigación del Cáncer

11 páginas‘Infection, Cancer and Prevention’, the Nineteenth International Symposium of the Foundation for Promotion of Cancer Research, was held in Tokyo on 21 – 23 February 2006. The symposium was organized by Drs Daizo Saito, Martin Blaser, Tadao Kakizoe, Kumao Toyoshima, Hiroshi Yoshikura, Toshiya Hirayama, Tadahito Kanda, Kunitada Shimotohno and Kensei Tobinai, with Dr Takashi Sugimura as advisor.‘Infección, Cáncer y Prevención’, el XIX Simposio Internacional de la Fundación para la Promoción de Cancer Research, se celebró en Tokio del 21 al 23 de febrero 2006. El simposio fue organizado por los Drs. Daizo Saito, Martin Blaser, Tadao Kakizoe, Kumao Toyoshima, Hiroshi Yoshikura, Toshiya Hirayama, Tadahito Kanda, Kunitada Shimotohno y Kensei Tobinai, con el Dr. Takashi Sugimura como aseso

Infection, cancer and prevention: Report of the 19th International Symposium of the Foundation for Promotion of Cancer Research

El 19º Simposio Internacional de la Fundación para la Promoción de la Investigación del Cáncer, "Infección, cáncer y prevención", se celebró en Tokio del 21 al 23 de febrero de 2006. El simposio fue organizado por los Dres. Daizo Saito, Martin Blaser, Tadao Kakizoe, Kumao Toyoshima, Hiroshi Yoshikura, Toshiya Hirayama, Tadahito Kanda, Kunitada Shimotohno y Kensei Tobinai, con el Dr. Takashi Sugimura como asesor.‘Infection, Cancer and Prevention’, the Nineteenth International Symposium of the Foundation for Promotion of Cancer Research, was held in Tokyo on 21–23 February 2006. The symposium was organized by Drs Daizo Saito, Martin Blaser, Tadao Kakizoe, Kumao Toyoshima, Hiroshi Yoshikura, Toshiya Hirayama, Tadahito Kanda, Kunitada Shimotohno and Kensei Tobinai, with Dr Takashi Sugimura as advisor